Background Raised blood pressure is an important risk factor for cardiovascular diseases and chronic kidney disease. We estimated worldwide trends in mean systolic and mean diastolic blood pressure, and the prevalence of, and number of people with, raised blood pressure, defi ned as systolic blood pressure of 140 mm Hg or higher or diastolic blood pressure of 90 mm Hg or higher.
Introduction
Raised blood pressure is the leading global risk factor for cardiovascular diseases and chronic kidney disease. 1 One of the global non-communicable disease (NCD) targets adopted by the World Health Assembly in 2013 is to lower the prevalence of raised blood pressure, defi ned as systolic blood pressure of 140 mm Hg or higher or diastolic blood pressure of 90 mm Hg or higher, by 25% compared with its 2010 level by 2025. 2 Consistent global information is needed to understand how countries compare on blood pressure levels and trends, and where interventions to curtail the rise in blood pressure are most needed.
The prevalence of raised blood pressure measures the number of high-risk people irrespective of treatment status, and is the indicator used in the global NCD target. However, blood pressure has a log-linear association with cardiovascular diseases and chronic kidney disease that continues well below the threshold for raised blood pressure, and treatment provides similar proportional risk reductions irrespective of pretreatment blood pressure. 3, 4 Trends in mean population blood pressure measure how blood pressure distribution has shifted over time.
We pooled population-based data to estimate national, regional, and global trends from 1975 to 2015 in mean systolic and mean diastolic blood pressure, and in the prevalence of raised blood pressure, for adults aged 18 years and older in 200 countries and territories. We also estimated trends in the number of adults with raised blood pressure, and calculated how much these trends are attributable to changes in prevalence versus changes in population size and age structure.
Methods

Study design and data sources
For this pooled analysis, we included data collected from samples of a national, subnational (ie, covering one or more subnational regions), or community (one or a small number of communities) population in which participants' blood pressure had been measured. Our methods for identifying and accessing data sources are described in the appendix (pp [2] [3] [4] [5] [6] . When a study measured blood pressure more than once in participants (1053 [86%] of 1220 studies for which information about number of measurements was available), we discarded the fi rst measurement, and used the average of the remainder.
292 (20%) of the 1479 data sources we analysed (2298 [16%] of 14 391 age-sex-study-specifi c data points) that were from a previous global pooling 5 or extracted from publications did not have data on one or more of our primary outcomes. We used regressions to convert available data in these sources to the missing primary outcomes because the various blood pressure outcomes are correlated. 6 Details of conversion (or so-called cross-walking) regressions and their coeffi cients are presented in the appendix (pp 7, 8, 44-152) .
Statistical analysis
The statistical model used to estimate means and prevalence by country, year, and age is described in detail in a statistical paper and related substantive papers. 5, 7, 8 In summary, we organised countries into 21 regions, mainly on the basis of geography and national income, which we further aggregated into nine "super-regions" (appendix pp 14, 15) . The model had a hierarchical structure in which estimates for each country and year were informed by its own data, if available, and by data from other years in the same country and from other countries, especially countries in the same region with data for similar time periods. The hierarchical structure shares information to a greater extent when data are nonexistent or weakly informative (eg, have a small sample size or are not national), and to a lesser extent for datarich countries and regions.
The model incorporated non-linear time trends and age patterns. It allowed the age association of blood pressure
Research in context
Evidence before this study We searched MEDLINE (via PubMed) for articles published in English, Spanish, Portuguese, Chinese, Italian, French, or Farsi between Jan 1, 1950, and Feb 19, 2014 , using the search terms ("blood pressure"[Mesh:NoExp] OR "hypertension"[Mesh:NoExp]) AND ("Humans"[Mesh]). We screened articles according to the inclusion and exclusion criteria described in the appendix.
Some studies, including the MONICA Project, have reported on blood pressure change or trends in one or more countries. Two previous global analyses, done more than a decade ago, pooled data from diff erent countries and reported mean systolic blood pressure or prevalence of hypertension in the year 2000 for the world and its major regions. A more recent analysis published in 2016 pooled 135 studies to estimate global and regional hypertension prevalence in 2000 and 2010, but did not report changes in mean blood pressure, which refl ect shifts in the population distribution of blood pressure. None of these studies provided consistent estimates for all countries or accounted for the fact that the data used were collected in diff erent years. The only analysis of trends at the country level reported mean systolic blood pressure from 1980 to 2008 but did not report mean diastolic blood pressure or prevalence of raised blood pressure, which is of clinical relevance and needed for monitoring progress towards the global target.
Added value of this study
This study provides the most complete picture of trends in adult blood pressure for all countries in the world with the longest observation period of any global blood pressure study to our knowledge, and includes trends in mean diastolic blood pressure and prevalence of raised blood pressure, which were not included in previous studies and are of clinical, public health, and health systems signifi cance. We also estimated trends in the number of adults with raised blood pressure, and how much these trends are driven by changes in prevalence versus population size and age structure.
Implications of all the available evidence
During the past four decades, the highest levels of blood pressure worldwide have shifted from high-income countries to low-income and middle-income countries in south Asia and sub-Saharan Africa, while blood pressure has been persistently high in central and eastern Europe. The global target of reducing raised blood pressure prevalence by 25% by 2025 is unlikely to be achieved in these regions. The number of people with raised blood pressure has risen worldwide, with the increase happening mainly in low-income and middle-income countries. Population-based interventions throughout the life-course and pharmacological treatment for people with high absolute risk or people with substantially raised blood pressure should be a part of any eff ort to address the global burden of non-communicable diseases, especially in the poorest countries.
See Online for appendix to vary across populations, and the rise in means and prevalence over age to be steeper where blood pressure is higher. 9, 10 The model accounted for the possibility that blood pressure in subnational and community studies might systematically diff er from nationally representative ones, and might also have larger variation than in national studies; the model also accounted for rural-urban diff erences in blood pressure, and used it to adjust rural-only and urban-only studies. The statistical model included covariates that help predict blood pressure, including mean number of years of education, proportion of national population living in urban areas, and a summary measure of availability of diff erent food types for human consumption (appendix pp 9, 10).
We fi tted the statistical model with the Markov chain Monte Carlo algorithm, and obtained 5000 post-burn-in samples from the posterior distribution of model parameters, which were in turn used to obtain the posterior distributions of primary outcomes. The reported credible intervals (CrI) represent the 2·5th to 97·5th percentiles of the posterior distributions. Each primary outcome was analysed separately, and all analyses were done separately by sex to allow blood pressure, its trends, and age associations to diff er among outcomes and between men and women.
We calculated mean change in mean blood pressure and the prevalence of raised blood pressure across the 41 years of analysis (reported as change per decade). We also report the posterior probability (PP) that an estimated trend represents a true increase or decrease. We generated age-standardised estimates using the WHO standard population, 11 by taking weighted means of age-sex-specifi c estimates, with use of age weights from the standard population. We tested how our statistical model predicted mean blood pressure and the prevalence of raised blood pressure when a country-year did not have data (appendix pp [11] [12] [13] , which showed that the model performed well in its predictive validity.
We calculated the contribution of population growth and ageing to the change in the number of adults with raised blood pressure by fi xing age-specifi c prevalence at its 1975 levels while allowing age-specifi c population to change as it did. We calculated the contribution of change in prevalence by fi xing age-specifi c population at its 1975 level while allowing age-specifi c prevalence to change as it did. The interaction between the two contributions is the residual change in the number of adults with raised blood pressure after accounting for the two forementioned components.
Role of funding source
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. Country and Regional Data Group members and BZ had full access to the data in the study. The corresponding author had fi nal responsibility for the decision to submit for publication.
Results
We included 1479 population-based measurement surveys and studies, with 19·1 million participants aged 18 years and older for whom blood pressure was measured. We had at least one data source for 174 (87%) of the 200 countries we made estimates for, covering 97·5% of the world's population in 2015 (appendix pp 193, 194) , and at least two data sources for 122 (61%) countries. Of these 1479 sources, 517 (35%) were from national samples, 249 (17%) covered one or more subnational regions, and the remaining 713 (48%) were from one or a small number of communities. Regionally, data availability ranged from 0·83 data sources per country in central Africa to 37 sources per country in high-income Asia Pacifi c. 543 (37%) data sources were from years before 1995 and another 936 (63%) were from 1995 and later.
Globally, age-standardised adult mean systolic blood pressure remained virtually unchanged from 1975 to 2015 in men (126·6 mm Hg [95% CrI 124·0 to 129·3] in 1975 and 127·0 mm Hg [125·7 to 128·3] in 2015; an increase of 0·07 mm Hg per decade [-0·59 to 0·74]; PP of being a true increasing trend is 0·5808) and decreased slightly in women (123·9 mm Hg [121·3 to 126·6] in 1975 and 122·3 mm Hg [121·0 to 123·6] in 2015; a decrease of 0·47 mm Hg per decade [-0·20 to 1·15]; PP=0·9210; fi gure 1). Trends in age-standardised mean diastolic blood pressure, which was 78·7 mm Hg (77·9 to 79·5) for men and 76·7 mm Hg (75·9 to 77·6) for women in 2015, were similar (fi gure 2).
Mean systolic and mean diastolic blood pressure decreased substantially during these four decades in high-income western and high-income Asia Pacifi c super-regions, moving these two super-regions from being among those with the highest blood pressure in 1975 to the lowest in 2015 (fi gures 1, 2). The largest decrease in mean systolic blood pressure, which occurred in high-income Asia Pacifi c, was 3·2 mm Hg per decade (95% CrI 2·4-3·9) for women and 2·4 mm Hg per decade (1·6-3·1) for men (PP>0·9999). The largest decrease in mean diastolic blood pressure, which was in the high-income western super-region, was 1·8 mm Hg per decade (1·4-2·3) for women and 1·5 mm Hg per decade (1·0-1·9) for men (PP>0·9999). Mean systolic blood pressure also seems to have decreased in women in central and eastern Europe, Latin America and the Caribbean, and, more recently, central Asia, Middle East, and north Africa, but the estimated trends in these super-regions had larger uncertainty than those in high-income super-regions; mean diastolic blood pressure showed a similar, but less pronounced, decrease in these super-regions (fi gures 1, 2). Little or no change in mean systolic or mean diastolic blood pressure occurred in men in these super-regions.
By contrast with these decreases, mean systolic blood pressure might have increased in men and women in east and southeast Asia, south Asia, Oceania, and sub-Saharan Africa, with a similar trend in mean diastolic blood pressure (fi gures 1,2). Central and eastern Europe, sub-Saharan Africa, and south Asia had the highest mean blood pressures in 2015.
Age-standardised prevalence of raised blood pressure decreased globally from 1975 to 2015, from 29·5% (95% CrI 24·2-35·0) to 24·1% (21·4-27·1) in men (PP=0·9482) and from 26·1% (21·7-31·1) to 20·1% (17·8-22·5) in women (PP=0·9884). The largest decrease was seen in high-income super-regions, followed by Latin America and the Caribbean, central Mean systolic blood pressure (mm Hg)
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Year 1 9 7 5 1 9 8 0 1 9 8 5 1 9 9 0 1 9 9 5 2 0 0 0 2 0 0 5 2 0 1 0 2 0 1 5 Year 1 9 7 5 1 9 8 0 1 9 8 5 1 9 9 0 1 9 9 5 2 0 0 0 2 0 0 5 2 0 1 0 1 9 7 5 1 9 8 0 1 9 8 5 1 9 9 0 1 9 9 5 2 0 0 0 2 0 0 5 2 0 1 0 2 0 1 Mean systolic and mean diastolic blood pressure were correlated across countries (correlation coeffi cients of 0·69 for men and 0·86 for women in 2015). However, men and women in countries in south Asia, central and eastern Europe, and central Asia, Middle East, and north Africa had higher diastolic blood pressure than expected on the basis of their systolic blood pressure and the systolic blood pressure-diastolic blood pressure association (fi gure 5); the opposite was seen for men and women in Oceania. South Korea, Canada, the USA, Peru, the UK, Singapore and Australia had the lowest prevalence of raised blood pressure in 2015 for both sexes, with an agestandardised prevalence of less than 13% in women and less than 19% in men (fi gure 4). At the other extreme, age-standardised prevalence surpassed 35% in men in some countries in central and eastern Europe including Croatia, Latvia, Lithuania, Hungary, and Slovenia; prevalence was more than 33% in women in a few countries in west Africa.
In 2015, men had higher age-standardised mean systolic blood pressure than women in most countries (fi gure 6). Men also had higher diastolic blood pressure and prevalence of raised blood pressure than women in most countries, except in sub-Saharan Africa, where the sex pattern was reversed in most countries, and a few countries in Oceania and Asia. The male-female diff erences in age-standardised means and prevalence were virtually all due to diff erences in people younger than 50 years; among people aged 50 years and older, on average men and women had similar mean systolic and diastolic blood pressure and prevalence of raised blood pressure, with countries divided into some with lower and others with higher male blood pressure (results not shown). The male-female diff erence in blood pressure in 2015 was largest in high-income countries and countries in central and eastern Europe. Compared with 1975, the male excess in mean blood pressure increased in high-income super-regions, central and eastern Europe, Latin America and the Caribbean, and central Asia, Middle East, and north Africa but decreased (and in the case of diastolic blood pressure reversed) in sub-Saharan Africa, Oceania, and south Asia (results not shown).
The estimated number of adults with raised blood pressure increased from 594 million in 1975 to 1·13 billion in 2015 (fi gure 7), comprising 597 million men and 529 million women. At the global level, this increase was attributable to population growth and ageing, off set partly by falling age-specifi c prevalence. In the high-income western super-region, the absolute number of people with raised blood pressure has decreased steadily since 1975 because the steep decrease in prevalence outweighed the eff ect of population growth and ageing. Nonetheless, 141 million adults in the constituent countries had raised blood pressure in 2015. Similarly, in central and eastern Europe, the number of people with raised blood pressure peaked in 1988 and went below its 1975 levels in 2002, driven by decreasing prevalence. In high-income Asia Pacifi c, the number of people with raised blood pressure has decreased since 2007 but is still higher than it was in 1975. In other For interactive maps and numerical results see www.ncdrisc.org
Figure 5: Relation between age-standardised mean systolic and mean diastolic blood pressure in men and women aged 18 years and older in 2015
The dotted line shows the linear association between the two outcomes. DBP=diastolic blood pressure. SBP=systolic blood pressure. Age-standardised mean SBP (mm Hg) Women low-income and middle-income super-regions, the number of people with raised blood pressure is still increasing. In Latin America and the Caribbean and central Asia, the Middle East, and north Africa, this rise is a net eff ect of increase due to population growth and ageing and decrease due to lower age-specifi c prevalence. In Oceania, south Asia, east and southeast Asia, and sub-Saharan Africa, three quarters or more of the rise is attributable to population growth and ageing, and the remainder is due to an increase in prevalence (fi gure 7). In 2015, 258 million (23%) of the 1·13 billion adults with raised blood pressure lived in south Asia (199 million of whom in India) and another 235 million (21%) lived in east Asia (226 million of whom in China).
Discussion
Raised blood pressure has transitioned from a risk factor largely aff ecting high-income countries to one that is now most prevalent in low-income countries in south Asia and sub-Saharan Africa, while being a persistent health issue in central and eastern Europe. Although favourable trends continue in high-income countries, and might also be happening in some middleincome regions, other low-income and middle-income regions are aff ected by rising, or at best stable but high, blood pressure. The number of people with raised blood pressure in the world has increased by 90% during these four decades, with the majority of the increase occurring in low-income and middle-income countries, and largely driven by the growth and ageing of the population. At the global level, we estimated lower mean systolic blood pressure in the 1980s, and hence a smaller reduction over time, than reported by Danaei and colleagues, 5 possibly because we had more data than their earlier analysis. At the regional level, the additional data from low-income and middle-income countries included in our analysis gave more confi dence to our fi nding of a rise in mean systolic blood pressure in Asia and sub-Saharan Africa than the trends estimated by Danaei and colleagues. 5 Our results cannot be directly compared with the studies by Kearney and colleagues 12 and Mills and colleagues 13 because these studies included people who used antihypertensive medicines when calculating prevalence. Despite this diff erence in the reported metric, the reports are broadly consistent in identifying central and eastern Europe, central Asia, and sub-Saharan Africa as regions at the highest risk. Lawes and colleagues 14 also reported the highest mean systolic blood pressure in central and eastern Europe and central Asia, as we did, but unlike our study they found lower mean systolic blood pressure in south Asia than in most regions. This diff erence is largely because blood pressure in south Asia has increased since 2000, the reporting year of Lawes and colleagues' study; the diff erence might also be attributable to us having substantially more data from south Asia than Lawes and colleagues.
The estimated decrease in blood pressure in highincome countries in our analysis is consistent with fi ndings of country studies and the MONICA Project. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] Fewer studies have analysed blood pressure trends in low-income and middle-income countries than in highincome countries. The available studies suggest reductions in blood pressure in central and possibly eastern Europe, [35] [36] [37] [38] the Middle East and north Africa, 39 and Latin America, 40 and increases in south Asia and sub-Saharan Africa, [41] [42] [43] and possibly in east and southeast Asia. 44, 45 We also found that the prevalence of raised blood pressure decreased in some regions where mean blood pressure did not change, and remained unchanged where the mean increased. Some other studies 32, 46 have also found a larger decrease in the upper tail of blood 1975 1980 1985 1990 1995 2000 2005 2010 2015 Year 1 9 7 5 1 9 8 0 1 9 8 5 1 9 9 0 1 9 9 5 2 0 0 0 2 0 0 5 2 0 1 0 2 0 1 5 Year 1 9 7 5 1 9 8 0 1 9 8 5 1 9 9 0 1 9 9 5 2 0 0 0 2 0 0 5 2 0 1 0 2 0 1 5 Year 1 9 7 5 1 9 8 0 1 9 8 5 1 9 9 0 1 9 9 5 2 0 0 0 2 0 0 with raised blood pressure, and the light blue sections show how much of the rise in numbers due to population growth and ageing has been off set by the decrease in prevalence.
pressure distribution than in its mean. In the MONICA Project, 16 the upper percentiles of blood pressure distribution decreased more than the mean in some communities but not in others. Although the changing shape of the distribution is partly due to antihypertensive drugs, it has also occurred in younger adult ages when medication use is uncommon. 32, 46 To investigate the drivers of the changing distribution would require historical data on multiple determinants of blood pressure throughout the life course. Finally, our fi nding of a higher mean blood pressure in men than in women, especially in premenopause ages, is consistent with previous studies. 47 The strengths of our study include its scope in making consistent and comparable estimates of trends in both mean and raised blood pressure over four decades for all the countries in the world. We used a large amount of population-based data covering countries in which more than 97% of the global adult population lives. We used only data from studies that had measured blood pressure to avoid bias in self-reported data. We analysed data according to a consistent protocol, and NCD Risk Factor Collaboration members verifi ed the characteristics of data from each country through repeated checks. We pooled data using a statistical model that took into account the epidemiological features of blood pressure, including non-linear time trends and age associations. Our statistical model used all available data while giving more weight to national data than to subnational and community sources.
Similar to all global analyses, our study is aff ected by some limitations. First, some countries had no or few data sources, especially those in sub-Saharan Africa and the Caribbean. Estimates for these countries relied mostly or entirely on the statistical model. The absence or scarcity of data is refl ected in wider uncertainty intervals of our estimates for these countries and regions, emphasising the importance of national NCD-oriented surveillance. Second, we had fewer data sources for the years before 1990 in most regions, which was refl ected in the larger uncertainty for these years. In a sensitivity analysis, we analysed trends starting in 1990 with an identical model, and compared the post-1990 estimates with estimates from the main analysis (which included data from 1975 onwards). The estimates were very similar with correlation coeffi cients between the estimates from the main and sensitivity analyses being 0·94 or higher in 1990 and 0·98 or higher in 2015 (appendix pp 197, 198) . Third, only 53% of sources included people older than 70 years, necessitating the use of data in these older ages elsewhere to infer an age pattern and make estimates in older ages. In view of the ageing trends throughout the world, inclusion of older people in health surveys should be emphasised. Fourth, our model accounted and adjusted for systematic and random errors in subnational and community data. However, the adjustments are not country-specifi c because estimation of country-specifi c adjustments would require national and subnational or community data in the same country and year. Therefore, the correction for each single country remains uncertain. Fifth, although data held by NCD Risk Factor Collaboration members were analysed to provide all the primary outcomes, individual participant data could not be accessed for 20% of data sources. To overcome this issue, we systematically used the reported metrics to estimate all of our primary outcomes; the cross-walking regressions used for this purpose had good predictive accuracy but increased the uncertainty of our estimates. Sixth, over time, standard mercury sphygmomanometers have been replaced by random-zero sphygmomanometers and more recently digital oscillometric devices in health surveys. Similarly, studies diff ered on whether they used multiple cuff sizes or one cuff size. We note that the eff ect of measurement device and protocol on population mean and prevalence depends on the circumstances of each survey. For example, an automated digital device with a standard cuff , although not the traditional goldstandard in a clinical setting, avoids observer bias and increases compliance, and possibly even response rate, compared with a standard mercury sphygmomanometer with multiple cuff s. 48 Nonetheless, measurements from diff erent devices are not fully comparable, [49] [50] [51] which might have aff ected the estimated trends. When we included device type as study-level covariate in our statistical model, studies using random-zero sphygmomanometers, which were used commonly in the late 1980s and 1990s, had lower mean blood pressure (by about 4·5 mm Hg for systolic blood pressure and by about 3 mm Hg for diastolic blood pressure) and prevalence of raised blood pressure than studies using standard mercury sphygmomanometers. The mean diff erence between studies using digital devices and mercury sphygmomanometers was about 2 mm Hg for systolic blood pressure and about 0·2 mm Hg for diastolic blood pressure. Finally, blood pressure had been measured only once in some of our data sources. In those sources with multiple measurements, the median diff erence between the fi rst measurement and the average of subsequent ones was 1·5 mm Hg for systolic blood pressure and 0·0 mm Hg for diastolic blood pressure, suggesting that mean blood pressure and prevalence of raised blood pressure might be slightly overestimated in some of our sources.
Blood pressure is a multifaceted trait, aff ected by nutrition, environment, and behaviour throughout the life course, including fetal and early childhood nutrition and growth, 52 adiposity, 53, 54 specifi c components of diet, especially sodium and potassium intakes, 53 alcohol use, 54, 55 smoking, 56 physical activity, 54 air pollution, 57 lead, 58 noise, 59 psychosocial stress, and the use of blood pressure lowering drugs. Changes in risk factors and improvements in detection and treatment of raised blood pressure have, at least partly, resulted in the decrease in blood pressure in high-income countries, although the decrease seems to have begun before or in the absence of specifi c interventions for risk factors and scale-up of treatment, and is only partly accounted for by the measured risk factors and treatment. 17, [19] [20] [21] 34, 35, 46, [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] In particular, the decrease in high-income and some middle-income countries has happened despite increasing body-mass index. 71 The partly unexplained nature of these favourable trends necessitates speculation about their drivers, which might include unmeasured improvements in early childhood nutrition and year-round availability of fruits and vegetables, which might increase the amount and regularity of their consumption. Our results show that similar decreasing trends in mean blood pressure and prevalence of raised blood pressure might have begun in some middle-income regions, although at a slower rate than trends in high-income regions, but not in the poorest populations, including those in south Asia and sub-Saharan Africa, and in populations aff ected by major social and economic changes in central and eastern Europe. These populations have low consumption of fresh fruits 72 and, in many cases, high consumption of salt. 73 South Asia and sub-Saharan Africa have the highest prevalence of maternal undernutrition, 71, 74 preterm and small-for-gestational age births, and child undernutrition; 75, 76 they have also had some of the smallest gains in adult height, 74 which is associated with lower risk of cardiovascular diseases. Many cases of raised blood pressure go untreated in these regions. 13, 77 The absence of these favourable determinants of low blood pressure, coupled with rising body-mass index, 71 might be causing the increase in mean blood pressure in these regions. Therefore, if governments and multinational organisations are to address the large and inequitable burden of cardiovascular diseases and kidney disease associated with high blood pressure, they need to take a multifaceted approach using both populationbased strategies throughout the life course and individual lifestyle management and treatment through primary care systems. 78 Contributors ME designed the study and oversaw research. Members of the Country and Regional Data Group collected and reanalysed data, and checked pooled data for accuracy of information about their study and other studies in their country. BZ and MDC led data collection. BZ and JB led the statistical analysis. BZ prepared results. Members of the Pooled Analysis and Writing Group collated data, checked all data sources in consultation with the Country and Regional Data Group, analysed pooled data, and prepared results. BZ and ME wrote the fi rst draft of the report with input from other members of the Pooled Analysis and Writing Group. Members of the Country and Regional Data Group commented on the draft report.
